icon-    folder.gif   Conference Reports for NATAP  
 
  11th IAS Conference on HIV Science 18-21 July 2021
Back grey_arrow_rt.gif
 
 
 
Week 72 Outcomes and COVID-19 Impact From the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in Black American Adults With HIV
 
 
  IAS 2021 July 18-21
 
Princy Kumar,1 Jeffrey L. Stephens,2 Anson K. Wurapa,3 Indira Brar,4 Mary J. Burton,5 Shauna Applin,6 Aditya Gaur,7 Moti Ramgopal,8 Paul Benson,9 Christiana Blair,10 Kristen Andreatta,10 Hiba Graham,10 Sean E. Collins,10 Diana M. Brainard,10 Debbie Hagins,11 on behalf of the BRAAVE 2020 Investigators 1MedStar Health, Washington, DC, USA; 2Mercer School of Medicine, Macon, Georgia, USA; 3Infectious Disease Specialists of Atlanta, P.C., Decatur, Georgia, USA; 4Henry Ford Hospital, Detroit, Michigan, USA; 5G.V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi, USA; 6Hilltop Family Medical Clinic, Community Health Care, Tacoma, Washington, USA; 7St. Jude Children’s Research Hospital, Memphis, Tennessee, USA; 8Midway Research Center, Fort Pierce, Florida, USA; 9Be Well Medical, Berkley, Michigan, USA;10Gilead Sciences, Inc., Foster City, California, USA; 11The Chatham CARE Center, Chatham County Health Dept, Savannah, Georgia, USA

0720211

0720212

0720213

0720214

0720215

0720216

0720217

0720218

0720219

07202110

07202111